HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor.
J
J
Lisziewicz
H
H
Jessen
D
D
Finzi
R F
RF
Siliciano
F
F
Lori
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D016049:Didanosine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D019469:Indinavir / Q000627:therapeutic use; D008297:Male
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D016049:Didanosine; D006918:Hydroxyurea